Keywords: Ceftobiprole; Pharmacokinetics/pharmacodynamics; Time–kill curves
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
In vitro activity of novel anti-MRSA cephalosporins and comparator antimicrobial agents against staphylococci involved in prosthetic joint infections
Keywords: Ceftaroline; Ceftobiprole; Staphylococcus aureus; CoNS; Prosthetic joint infection; PJI;
Antimicrobial activity of ceftobiprole and comparator agents when tested against contemporary Gram-positive and -negative organisms collected from Europe (2015)
Keywords: Ceftobiprole; Surveillance; Antimicrobial resistance;
Recently approved antibacterials for methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive pathogens: the shock of the new
Keywords: Staphylococcus aureus; Tedizolid; Dalbavancin; Ceftaroline; Ceftobiprole; Oritavancin;
In vitro activity of ceftobiprole on 440 Staphylococcus aureus strains isolated from bronchopulmonary infections
Keywords: Ceftaroline fosamil; Ceftobiprole; Bronchopulmonary infections; Staphylococcus aureus; Céftaroline; Céftobiprole; Infections broncho-pulmonaires; Staphylococcus aureus;
Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)
Keywords: carbapenem; ceftobiprole; colistin; intensive care unit; nonsusceptibility;
Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types
Keywords: Ceftobiprole; MRSA; Antimicrobial resistance;
Evaluation of the in vitro activities of ceftobiprole and comparators in staphylococcal colony or microtitre plate biofilm assays
Keywords: Ceftobiprole; Biofilm; Staphylococcus; Antibiotic resistance
A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation
Keywords: Ceftobiprole; Community-acquired pneumonia; Streptococcus pneumoniae
Use of Enzyme Inhibitors to Evaluate the Conversion Pathways of Ester and Amide Prodrugs: A Case Study Example with the Prodrug Ceftobiprole Medocaril
Keywords: prodrug; drug metabolizing enzymes; in vitro models; inhibition; enzymology; hydrolysis; conversion; paraoxonase; esterase; ceftobiprole;
In vitro antibacterial activity of ceftobiprole against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints
Keywords: Ceftobiprole; New cephalosporin; In vitro activity; Breakpoints;
In vitro activities of ceftobiprole combined with amikacin or levofloxacin against Pseudomonas aeruginosa: evidence of a synergistic effect using time-kill methodology
Keywords: Ceftobiprole; Pseudomonas aeruginosa; Kill curve; Synergism; Combination;
In vitro activity of ceftobiprole against frequently encountered aerobic and facultative Gram-positive and Gram-negative bacterial pathogens: results of the CANWARD 2007–2009 study
Keywords: Ceftobiprole; Vancomycin; Hospitals
Ceftobiprole: The First Broad-Spectrum Anti–methicillin-resistant Staphylococcus aureus Beta-Lactam
Keywords: antibiotic; ceftobiprole; cephalosporin; complicated skin and skin structure infections; pneumonia
Newer Beta-lactam Antibiotics: Doripenem, Ceftobiprole, Ceftaroline, and Cefepime
Keywords: Beta-lactam; Doripenem; Ceftobiprole; Ceftaroline; Cefepime;
Effect of ceftobiprole on the normal human intestinal microflora
Keywords: Ceftobiprole; Normal human intestinal microflora
Ceftobiprole: a novel cephalosporin with activity against Gram-positive and Gram-negative pathogens, including methicillin-resistant Staphylococcus aureus (MRSA)
Keywords: Ceftobiprole; MRSA; Pharmacokinetics; Pharmacodynamics
New therapeutic choices for infections caused by methicillin-resistant Staphylococcus aureus
Keywords: MRSA; treatment; gram positives; linzolid; vanomycin; daptomycin; tigecycline; ceftobiprole; ceftarole; review;
Newer Beta-lactam Antibiotics: Doripenem, Ceftobiprole, Ceftaroline, and Cefepime
Keywords: Beta-lactam; Doripenem; Ceftobiprole; Ceftaroline; Cefepime;
In vitro activity of ceftobiprole, linezolid, tigecycline, and 23 other antimicrobial agents against Staphylococcus aureus isolates in China
Keywords: Staphylococcus aureus; MRSA; ceftobiprole; linezolid; tigecycline
Ceftobiprole: breaking therapeutic dogmas of the β-lactam class
Keywords: Staphylococcus aureus; MRSA; Antimicrobial; Ceftobiprole; Gram positive; Gram negative; β-lactam;
New antibiotic agents for bloodstream infections
Keywords: Bloodstream infections; Daptomycin; Linezolid; Quinupristin/dalfopristin; Tigecycline; Dalbavancin; Telavancin; Oritavancin; Ceftobiprole; Doripenem; Colistin; Antibiotic lock therapy; Continuous intravenous antibiotic administration
The efficacy and safety of ceftobiprole in the treatment of complicated skin and skin structure infections: evidence from 2 clinical trials
Keywords: Complicated skin and skin structure infection; MRSA; Staphylococcus aureus; Gram positive; Gram negative; Cephalosporin; Ceftobiprole; Antimicrobial
Pharmacokinetic and pharmacodynamic profile of ceftobiprole
Keywords: Cephalosporin; Ceftobiprole; Gram-positive; Staphylococcus aureus; MRSA; Gram-negative; Pseudomonas aeruginosa; Monte Carlo simulation
Antimicrobial activity of ceftobiprole, a novel anti–methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005–2006)
Keywords: Ceftobiprole; Antimicrobial susceptibility; Methicillin resistant; Staphylococcus aureus, Surveillance
New antimicrobial agents for the treatment of Gram-positive bacterial infections
Keywords: Ceftobiprole; daptomycin; linezolid; quinupristin–dalfopristin; review; tigecycline
New and emerging treatment of Staphylococcus aureus infections in the hospital setting
Keywords: Ceftobiprole; MRSA; PBP2a; resistance; review; SCCmec
Activity of ceftobiprole against community-associated methicillin-resistant Staphylococcus aureus isolates recently recovered from US military trainees
Keywords: Ceftobiprole; MRSA; CA-MRSA; Military
Antianaerobe activity of ceftobiprole, a new broad-spectrum cephalosporin
Keywords: Anaerobes; Ceftobiprole; MIC; Susceptibility
Clinical profile of ceftobiprole, a novel β-lactam antibiotic
Keywords: ceftobiprole; cephalosporin; Gram-negative; Gram-positive; MRSA
Combating resistance in a challenging, changing environment
Keywords: Antimicrobial resistance; ceftobiprole; methicillin-resistant Staphylococcus aureus; MRSA; vancomycin
In-vitro profile of a new β-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus
Keywords: Ceftobiprole; in vivo; in vitro; MRSA; PBP2′
Can β-lactams be re-engineered to beat MRSA?
Keywords: Antimicrobial resistance; β-lactam antibiotics; ceftobiprole; MRSA
Ceftobiprole: in-vivo profile of a bactericidal cephalosporin
Keywords: Antimicrobial resistance; ceftobiprole; in vivo; MRSA
MRSA—the tip of the iceberg
Keywords: Ceftobiprole; community-acquired; methicillin-resistant Staphylococcus aureus; vancomycin